)
)
Annovis Bio Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Annovis Bio Inc
Access all reports
Annovis Bio Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other central nervous system disorders. The company specializes in small molecule therapies designed to reduce neurotoxic proteins and improve brain function. The company is headquartered in Berwyn, Pennsylvania, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ANVS
Country
🇺🇸 United States